Pancreatic ductal adenocarcinomas (PDACs) are highly metastatic with poor prognosis, mainly due to delayed detection. We hypothesized that intercellular communication is critical for metastatic progression. Here, we show that PDAC-derived exosomes induce liver pre-metastatic niche formation in naive mice and consequently increase liver metastatic burden. Uptake of PDAC-derived exosomes by Kupffer cells caused transforming growth factor β secretion and upregulation of fibronectin production by hepatic stellate cells. This fibrotic microenvironment enhanced recruitment of bone marrow-derived macrophages. We found that macrophage migration inhibitory factor (MIF) was highly expressed in PDAC-derived exosomes, and its blockade prevented liver pre-metastatic niche formation and metastasis. Compared with patients whose pancreatic tumours did not progress, MIF was markedly higher in exosomes from stage I PDAC patients who later developed liver metastasis. These findings suggest that exosomal MIF primes the liver for metastasis and may be a prognostic marker for the development of PDAC liver metastasis.
niches, a sequence of events that prepares future metastatic sites for the influx of tumour cells and that supports engraftment and survival of these incoming metastatic cells 9, 14, 15 , has been shown to depend on tumour-derived exosomes 16, 17 .
Here, we present for the first time a detailed analysis of the sequential steps involved in liver pre-metastatic niche formation in the context of pancreatic cancer metastasis. We demonstrate that exosomes derived from malignant pancreatic lesions play a key role in liver pre-metastatic niche initiation. Selective uptake of exosomes by Kupffer cells (KCs) in the liver causes activation of fibrotic pathways, and the establishment of a pro-inflammatory milieu that ultimately supports metastasis. Specifically, we show that exosomal MIF induces the release of transforming growth factor β (TGFβ) by KCs, which, in turn, promotes fibronectin (FN) production by hepatic stellate cells (hStCs). FN deposits subsequently promote the arrest of bone marrow-derived macrophages and neutrophils in the liver, completing the formation of the pre-metastatic niche. MIF knockdown prevents all sequential steps in liver pre-metastatic niche formation and, as a result, blocks exosome-induced PDAC metastasis. Importantly, we demonstrate that MIF is elevated in plasma exosomes isolated from a mouse model of pancreatic cancer (PKCY mice) bearing either pancreatic intraepithelial neoplasia (PanIN) or PDAC lesions. Moreover, MIF is also highly expressed in plasma exosomes isolated from PDAC patients whose disease progressed post-diagnosis relative to patients with no evidence of disease five years post-diagnosis and to healthy control subjects. These observations suggest that exosomal MIF may be a marker, as well as a functional component, of PDAC liver metastasis. In summary, our study describes a previously unknown pro-metastatic circuit through which PDAC-derived exosomes can induce the formation of liver pre-metastatic niches that foster the development of metastatic disease.
RESULTS

PDAC-derived exosomes preferentially fuse with KCs and enhance metastatic burden in the liver
To determine whether PDAC-derived exosomes play a role in liver metastasis, we used an experimental model of intrasplenic injection of PAN02 murine PDAC cells 18, 19 , which typically generates metastases restricted to the liver. We first analysed the structure of PAN02-derived exosomes by electron microscopy, which revealed a typical exosome structure and size of approximately 100 nm ( Supplementary Fig. 1a ). Naive, wild-type mice were injected retro-orbitally every other day for three weeks with 5 µg of PAN02-derived exosomes in a process that we previously defined as 'education' 16 . After exosome education, we injected mCherry + PAN02 cells intrasplenically (into the portal circulation) and analysed the incidence of liver metastasis. We found that exosome education increased macrometastatic burden 21 days after injection, as demonstrated by quantification of mCherry + cells (Fig. 1a , left and middle panels) and by measurement of liver weight (Fig. 1a, right panel) . We verified that a control cohort educated with exosomes isolated from conditioned media of primary cultures of normal pancreatic tissue (NP) from tumour-free mice did not cause an increase in metastatic burden (Fig. 1b) . Furthermore, education with exosomes derived from two additional murine PDAC cell lines isolated from tumours developed in the KPC (ref. 20) and PKCY (ref. 21) mouse models (hereon referred to as R6560B and PKCY, respectively) resulted in increased liver metastatic burden, as assessed three weeks after injection of PAN02 cells ( Supplementary Fig. 1b ). These data suggest that PDAC-derived exosomes may support early tumour cell engraftment and metastasis by conditioning metastatic organs with favourable microenvironments (that is, pre-metastatic niches).
We next evaluated the cells that take up tumour exosomes in the liver following retro-orbital injection of labelled PDAC-derived exosomes in naive mice. For this purpose, we used fluorescently labelled exosomes isolated from several PDAC models, including PAN02, PKCY and R6560B, as well as human BxPC-3 and HPAF-II PDAC cells. By analysing the frequency of exosome-positive cells in a million cells from each organ, we found that in all cases, although they first circulate through the lung owing to the retroorbital injection methodology, PDAC-derived exosomes were more frequently represented in the liver than in the lung ( Supplementary  Fig. 1c ). In addition, we found that over 80% of liver cells that take up exosomes were F4/80
+ by immunofluorescence or F4/80 + CD11b
+ by flow cytometry, a phenotype consistent with KCs ( Fig. 1c,d and Supplementary Fig. 1d ). In contrast, control exosomes isolated from healthy normal murine pancreata were not efficiently incorporated by KCs or other tissues analysed (Fig. 1c,d and Supplementary Fig. 1c ). Importantly, PDAC exosomes failed to fuse with other cells in the liver microenvironment, such as αSMA + hStCs, S100A4 + fibroblasts, CD31
+ endothelial cells or EpCAM + epithelial cells ( Supplementary  Fig. 1e ). Therefore, our data suggest that KCs are the predominant cell type that takes up PDAC-derived exosomes and that they are probably responsible for promoting the initial steps of liver pre-metastatic niche formation.
To further define mechanisms involved in liver pre-metastatic niche formation by KCs, we educated human KCs with PAN02 or BxPC-3 exosomes in vitro and performed gene expression analysis by mRNA sequencing. Our data demonstrate that, of more than 300 canonical pathways, the liver fibrosis pathways-particularly those associated with the upregulation of genes encoding soluble factors such as CTGF, EDN, IGF, PDGF and TGFβ ( Fig. 1e and Supplementary Fig. 1f )-were the most highly expressed and overrepresented (Supplementary Tables 1 and 2) .
FN upregulation by hStCs is important for liver pre-metastatic niche formation by PDAC-derived exosomes
To determine how PDAC-derived exosomes elicit a fibrotic liver microenvironment, we examined, by immunofluorescence, the changes in expression of different extracellular matrix (ECM) proteins following PAN02 exosome education. We observed a downregulation of vitronectin and tenascin C, a stable but minimal expression level of collagen type I, and a marked increase in FN expression (Fig. 2a) . Next, we investigated the source of FN upregulation by PDACderived exosomes by co-staining sections of pre-metastatic livers with antibodies against FN and CD31 or αSMA. We found a predominant population of αSMA + FN + cells in FN-enriched areas of educated livers, but a lack of FN and CD31 co-staining ( Supplementary Fig. 2a ), suggesting that activated hStCs produced most of the FN (Fig. 2b) . In contrast to education with NP-derived exosomes, education of naive mice with PKCY or R6560B cell-derived exosomes also increased αSMA and FN expression in the liver (Supplementary Fig. 2b ). These results demonstrate an induction of FN production by hStCs and Figure 1 PDAC-derived exosomes target and activate KCs, induce liver fibrosis pathways, and increase liver metastasis. (a) Evaluation of liver metastasis by liver weight (grams) in mice injected intrasplenically with PAN02 cells (TU, for tumour bearing) following pre-education with phosphate-buffered saline (PBS) or PAN02 exosomes (Exo). Percentage of mCherry + PAN02 cells in the liver was measured by immunofluorescence (left panels; n = 4 mice were pooled from two independent experiments) and livers were weighed (right panel; n = 9 (CTL) and n = 8 (TU and Exo+TU) mice were pooled from three independent experiments) at day 21 post-PAN02 cell injection. Representative liver images are shown. * * P < 0.01 by two-tailed t-test (middle panel), * * * P < 0.001 by ANOVA (right panel). Scale bars, immunofluorescence: 200 µm, whole organ images: 1 cm. (b) Evaluation of liver metastasis by liver weight (grams) in mice pre-educated with PBS, exosomes from PAN02 cells, or normal pancreata (NP) before intrasplenic injection of PAN02 cells; n = 4 (TU) and n = 5 (PAN02exo + TU and NPexo + TU) mice from one experiment. * * P < 0.01 by ANOVA. support the hypothesis that PDAC-derived exosomes can establish a fibrotic liver pre-metastatic niche.
PDAC-derived exosomes induce bone marrow-derived cell migration to liver
To evaluate whether PDAC-derived exosomes play a role in preparing the liver microenvironment for the arrival of metastatic cells by eliciting macrophage recruitment, wild-type mice were educated with exosomes isolated from PAN02, PKCY or R6560B cells. Interestingly, PDAC exosomes, but not NP exosomes, were sufficient to increase the frequency of cells expressing the macrophage marker F4/80 in the liver (Fig. 3a and Supplementary Fig. 2c ). A detailed time course analysis during the three-week PAN02 exosome education showed a significant increase in FN levels as early as the second week of exosome education. By the third week of education, we observed a significant and sustained increase in the levels of F4/80 + cells in educated livers compared with livers that had not been educated (Fig. 3a) . Moreover, to determine whether the increase in macrophage frequency was the result of bone marrow-derived macrophage recruitment, we transplanted GFP-expressing bone marrow cells into irradiated wildtype C57Bl/6 mice, followed by PAN02 exosome education and F4/80 immunostaining. We observed an overall increase in GFP + cells in the liver after exosome education, with approximately 67% of these cells being F4/80 + (Fig. 3b , upper panels). Importantly, the GFP − F4/80 + population, probably composed of liver-resident KCs, remained unchanged after PAN02 exosome education (Fig. 3b , upper-right panel). Furthermore, we found that a smaller subset, approximately 30% of the GFP + cells, was positive for the myeloid differentiation marker Gr-1, and this population also increased in the liver following PAN02 exosome education (Fig. 3b , lower panels). Our results indicate that PAN02 exosome education promotes recruitment of bone marrow-derived cells to the liver, including F4/80 + macrophages and, to a lesser extent, Gr-1 + neutrophils.
Macrophage recruitment to the liver pre-metastatic niche follows TGFβ signalling-induced FN upregulation
Following KC education with PDAC-derived exosomes in vitro, TGFβ was among the most highly upregulated soluble factors related to liver fibrosis and hStC activation (60-148% increase) produced by KCs ( Fig. 1e and Supplementary Fig. 1f ). TGFβ mediates fibrogenesis by inducing hStC activation and myofibroblast differentiation, leading to ECM protein production [22] [23] [24] [25] [26] . We therefore reasoned that KC-derived TGFβ might be responsible for inducing FN production by hStCs (refs 27,28) . Consistent with this hypothesis, treatment with a TGFbeta type I receptor inhibitor (A83-01; ref. 29) during the threeweek course of PAN02 exosome education reduced the frequency of αSMA + hStCs, FN deposition, and F4/80 + macrophage migration to the liver ( Fig. 4 and Supplementary Fig. 3 ). Thus, FN deposition and macrophage recruitment are both TGFβ-dependent steps that occur during liver pre-metastatic niche formation.
To further define the sequential events involved in liver premetastatic niche development, we used a conditional FN knockout murine model in which tamoxifen-driven Cre recombinase expression depletes FN during PAN02 exosome education. We verified that FN deposition in the liver was reduced to control Rosa-CreER − ;Fn fl/fl levels following tamoxifen treatment of Rosa-CreER + ;Fn fl/fl , whereas αSMA expression was not affected (Fig. 5a ). Interestingly, FN depletion led to a reduction in the frequency of F4/80 + macrophages in the liver, demonstrating that FN deposition is required to increase macrophage frequency in the pre-metastatic liver (Fig. 5a ). To examine whether FN depletion plays a functional role in PDAC liver metastasis, we intrasplenically injected PAN02 cells into tamoxifen-treated Rosa-CreER + ;Fn fl/fl and control (Rosa-CreER − ;Fn fl/fl ) mice educated with PAN02 exosomes. Consistent with our hypothesis that FN plays a critical role in liver pre-metastatic niche formation, FN depletion during the three-week PAN02 exosome education step reverted the ; n = 4 (F4/80) and n = 3 (Gr-1) mice from one experiment. * * P < 0.01, * P < 0.05 by two-tailed t-test. Scale bars, 50 µm. All statistical source data are presented in Supplementary Table 4 . All data are represented as mean ± s.e.m.
pro-metastatic phenotype to resemble livers collected from PBSeducated PAN02 tumour-bearing mice (Fig. 5b) . Of note, reduction of FN levels in non-educated mice using the same system did not affect baseline liver metastasis (Fig. 5c ). Our results confirm that FN is required for PDAC exosome-mediated liver pre-metastatic niche formation.
Macrophage ablation blocks the pro-metastatic effect of PDAC-derived exosomes in the liver
Bone marrow macrophages are recruited to the liver during the early stages of exosome-mediated liver pre-metastatic niche formation. Therefore, we first investigated whether macrophages present in the liver pre-metastatic niche are physically associated with liver metastatic lesions. To this end, we tracked disseminated PAN02 cells in the livers of mice educated for three weeks with PAN02 exosomes, 24 h after splenic injection. We found that metastatic cells localized adjacent to F4/80 + macrophages ( Supplementary  Fig. 4) . Next, we sought to determine whether macrophages are required for liver pre-metastatic niche formation. To distinguish between direct effects of FN deposition and FN-mediated effects on liver F4/80 + cell frequency during PAN02 exosome-mediated liver pre-metastatic niche formation and liver metastasis, we used a diphtheria toxin (DT)-inducible system that transiently depletes CD11b + cells (including macrophages and neutrophils) expressing the DT receptor 30 (DTR). DT treatment during the second week of PAN02 exosome education significantly reduced the frequency of F4/80 + macrophages without affecting αSMA + hStC or FN levels in the liver ( Fig. 5d and Supplementary Fig. 3 ). We then examined the effects of macrophage depletion on metastatic progression by injecting PAN02 cells into exosome-educated mice depleted of CD11b + cells. Macrophage depletion was sufficient to revert the effects of PAN02 exosome education on liver metastasis (Fig. 5e ). Of note, reduction of macrophage levels in non-educated mice using the same approach did not alter baseline liver metastasis (Fig. 5f ). Taken together, these results suggest that macrophages are required for liver pre-metastatic niche-dependent metastasis formation. 
MIF depletion in PDAC-derived exosomes inhibits liver pre-metastatic niche initiation
To gain insight into the mechanisms through which PDAC-derived exosomes promote KC activation and subsequent liver pre-metastatic niche formation, we mined pancreatic exosome mass spectrometry data for potential inflammatory mediators. Among the candidates with previously described roles in either or both macrophage activation and inflammatory modulation, we found that MIF was highly expressed in PDAC-derived exosomes (Supplementary Table 3 ). MIF knockdown in PAN02 cells did not affect exosome size, quantity of protein per exosome, or the binding of these exosomes to liver CD11b + F4/80 + cells ( Supplementary Fig. 5a-c) . However, the effects of MIF knockdown on liver pre-metastatic niche formation were striking, as evidenced by a pronounced reduction of TGFβ expression in F4/80 + cells and of αSMA in hStCs ( Fig. 6a  and Supplementary Fig. 3 ). Moreover, MIF knockdown decreased both FN deposition and F4/80 + macrophage frequency ( Fig. 6a  and Supplementary Fig. 3 ). Additionally, we observed a reduction in tumour cell retention after 24 h in mice educated with PAN02 MIF knockdown exosomes, compared with control PAN02 exosomes ( Supplementary Fig. 5d ). These results suggest that MIF orchestrates the sequential events in PDAC-derived exosome-induced liver premetastatic niche formation.
To further evaluate the functional role of exosomal MIF in liver metastatic progression, we compared the consequences of intrasplenic injection of PAN02 cells into non-educated mice versus mice preeducated with either PAN02 or PAN02 MIF knockdown exosomes for three weeks. In addition to preventing KC education and the sequential steps in liver pre-metastatic niche induction by PAN02 exosomes (Fig. 6a ) and analogous to TGFβ1R signalling inhibition by A83-01 (Fig. 4) , MIF knockdown also reduced the ability of PAN02 exosomes to promote liver metastasis (Fig. 6b,c) . Control lentiviral vectors did not alter the effects of PAN02 exosomes on liver pre-metastatic niche formation (Fig. 6a,c) . Collectively, our data demonstrate that exosomal MIF is mediating the increase in metastatic burden observed on PDAC-derived exosome education.
Next, we sought to determine the clinical relevance of these findings. To this end, we explored whether MIF levels varied between exosomes isolated from plasma samples of control healthy subjects and PDAC patients with liver metastasis, with either no evidence of disease (NED) five years post-diagnosis or progression of disease (POD) postdiagnosis. We found that POD patients expressed significantly higher exosomal MIF levels compared with NED patients and healthy control subjects, suggesting that exosomal MIF could be used as a biomarker of PDAC prognosis. A trend towards lower MIF levels was apparent in exosomes isolated from PDAC patients with liver metastasis versus those with POD, although the difference between patient groups was not statistically significant (Fig. 6d) . Taken together, our findings indicate that MIF-expressing exosomes are essential for liver premetastatic niche initiation and efficient liver metastasis.
Liver pre-metastatic niche formation precedes the establishment of PDAC lesions
To further characterize changes in the liver niche during metastatic progression, we analysed the livers of PKCY mice that develop PDAC with reproducible kinetics, starting with 'early' PanIN lesions at 4-6 weeks, more advanced PanINs at 8-11 weeks, and invasive cancers at [16] [17] [18] [19] [20] weeks that metastasize to the liver 21 . Livers isolated from mice that do not develop pancreatic lesions (Cre transgenic mice lacking activating Tp53 and Kras mutations, from hereon referred to as CY mice) were used as controls. We found an increase in αSMA (Fig. 7a) . Next, we evaluated TGFβ expression levels during pancreatic cancer progression in PKCY mice. Importantly, we found that TGFβ was upregulated in KCs during the early PanIN stage (twofold), suggesting that PDAC-derived exosomes play a role during the pre-tumoral stages of liver pre-metastatic niche formation (Fig. 7a) . Finally, to , FN) , n = 6 (CRE + F4/80), n = 7 (CRE − αSMA, F4/80), and n = 8 (CRE − FN; CRE + αSMA, FN) mice from two experiments. * * * P < 0.001, * * P < 0.01 by ANOVA. (b) Evaluation of liver metastasis by liver weight (grams) in tumour-free mice (CTL), PBS-educated mice injected intrasplenically with PAN02 cells (TU), and tumour-bearing CRE − and CRE + mice TMX-treated during Exo education; n = 4 (CTL), n = 6 (CRE − and CRE + ), and n = 10 (TU) mice from three experiments. * * * P < 0.001, * P < 0.05 by ANOVA. (c) Evaluation of liver metastasis in TMX-treated CRE − versus CRE + mice injected intrasplenically with PAN02 cells (TU); n = 4 (CRE + ) and n = 5 (CRE − ) mice from one experiment. (d) Quantification of FN and αSMA expression and F4/80 + cell frequency in mice transiently depleted of CD11b + cells using a diphtheria toxin (DT)-inducible system during PAN02 exosomes (Exo) education. As control, PBS-educated livers (CTL); n = 3 (CTL F4/80), n = 4 (CTL αSMA, FN; DTR − αSMA), n = 7 (DTR − FN, F4/80; DTR + αSMA, FN), and n = 9 (DTR + F4/80) mice from two experiments. * * * P < 0.001, * * P < 0.01 by ANOVA. (e) Evaluation of liver metastasis in tumour-free mice (CTL), PBS-educated mice injected intrasplenically with PAN02 cells (TU), and tumour-bearing CD11b-DTR − or -DTR + mice DT-treated during Exo education; n = 5 (CTL), n = 6 (DTR − ), n = 9 (DTR + ), and n = 10 (TU) mice pooled from three experiments. * * * P < 0.001, * * P < 0.01 by ANOVA. (f) Evaluation of liver metastasis in mice transiently depleted of CD11b + cells and injected intrasplenically with PAN02 cells; n = 4 (DTR − ) and n = 5 (DTR + ) mice from one experiment. All data are represented as mean ± s.e.m. NS: not significant by two-tailed t-test. Scale bars, immunofluorescence: 200 µm, whole organ: 1 cm. (CTL, TU, Exo+TU, and shMIFexo+TU) mice pooled from two experiments. * * P < 0.01, * P < 0.05 by ANOVA. Scale bar, 1 cm. (c) Evaluation of liver metastasis in mice injected intrasplenically with PAN02 cells preeducated with PBS (TU), or with exosomes isolated from PAN02 cells infected with control shRNA (shCTLexo+TU) or shMIF(2)) (shMIF(2)exo+TU) lentiviral vectors; n = 4 (shCTLexo+TU), n = 5 (shMIF(2)exo+TU), and n = 6 (TU) mice from one experiment. * * * P < 0.001 by ANOVA. Scale bar, 1 cm. (d) Enzyme-linked immune assay (ELISA) reveals increased levels of MIF (picogram per 10 8 exosomes) in exosomes isolated from patients with PDAC with progression of disease post-diagnosis (POD) compared with PDAC patients with no evidence of disease 5 years post-diagnosis (NED) and with healthy controls (CTL), but not PDAC patients with liver metastasis (LM); n = 10 (NED), n = 12 (POD), n = 15 (CTL), and n = 18 (LM) patients. All patient samples were analysed once as part of three independent ELISA assays. * * P < 0.01 by ANOVA. All data are represented as mean ± s.e.m. determine whether exosomal MIF protein levels correlate with the progression of pancreatic lesions, we evaluated exosomes isolated from the plasma of PKCY mice at different stages of pancreatic lesion progression. We found increased levels of MIF in exosomes from mice with PDAC when compared with exosomes from healthy control mice (Fig. 7b) . Interestingly, the increase in exosomal MIF levels was already detectable in exosomes isolated from mice with PanIN lesions (early or late stage; Fig. 7b ). Collectively, these results demonstrate that changes in MIF levels in PDAC-derived exosomes reflect liver pre-metastatic niche formation during pre-malignant stages of PDAC metastatic progression.
DISCUSSION
Circulating exosomes can be used as biological markers for pancreatic cancers 4, 31 . However, the cellular and molecular mechanisms through which PDAC-derived exosomes affect metastasis have yet to be determined. Here, we delineate for the first time the sequential steps of liver pre-metastatic niche formation by PDAC-derived exosomes. PDAC-derived exosomes induce TGFβ signalling in KCs, leading to activation of hStCs and ECM remodelling. In turn, FN accumulation promotes an influx of bone marrow-derived macrophages (and potentially neutrophils) to the liver, providing a favourable niche for liver metastasis (Fig. 8) . Importantly, we demonstrate that this stepwise progression also occurs in a spontaneous murine model of pancreatic cancer, the PKCY mouse model, in which key early liver pre-metastatic niche features (such as hStC activation, FN accumulation, and macrophage recruitment to the liver) are already evident during the PanIN stages.
Unbiased mass spectrometry analysis of PDAC-derived exosome protein cargo led us to identify MIF as a candidate mediator of liver education. Although one study has described MIF as an anti-fibrotic factor in a chemically induced liver fibrosis model 32 , MIF is a well-known Figure 8 Model for the sequential steps in liver pre-metastatic niche formation induced by PDAC-derived exosomes. Education with MIF + PDAC-derived exosomes, which bind predominantly to KCs in the liver, induces TGFβ production by these cells. TGFβ activates hStCs, which, in turn, upregulate FN. Bone marrow-derived cells (that is, macrophages and granulocytes) bind to FN-enriched hepatic sites, ultimately leading to liver pre-metastatic niche formation.
MIF + exosomes
mediator of liver inflammation and fibrosis, of bone marrow cell recruitment to the liver, and of liver metastasis, and furthermore, MIF tissue and plasma levels correlate with PDAC aggressiveness [33] [34] [35] [36] [37] . Here, we propose a new role for exosomal MIF in PDAC liver metastasis and describe a mechanism through which MIF orchestrates this process.
Our functional experiments in murine models of PDAC demonstrate that exosomal MIF upregulation is an early event during cancer progression and can be detected in plasma-derived exosomes isolated from mice with pre-tumoral pancreatic lesions. Importantly, high exosomal MIF levels were present in plasma from patients with stage I PDAC, before liver metastasis, indicating its potential prognostic value. In contrast, exosomal MIF levels had a bimodal distribution in patients with established liver metastatic disease. The presence of low exosomal MIF levels in a subset of PDAC patients with liver metastasis indicates that MIF-dependent mechanisms may be more important during earlier stages of liver metastasis. Taken together, these observations justify future long-term retrospective and prospective studies to determine whether exosomal MIF levels could serve as an early biomarker for liver pre-metastatic niche formation and a prognostic factor for metastatic risk in patients with pre-tumoral lesions, such as pancreatitis, PanINs, intraductal papillary mucinous neoplasms, and pre-metastatic PDACs. Moreover, these results also raise the possibility that high MIF levels may be an indicator of risk for liver pre-metastatic niche formation and liver metastasis in other gastrointestinal tract tumours, such as colorectal and gastric cancer. MIF inhibition by either small molecules or neutralizing antibodies has been shown to prevent macrophage activation, TGFβ expression, and tissue fibrosis [38] [39] [40] [41] . Further studies are required to determine the effects of systemic MIF inhibition on liver pre-metastatic niche formation and its therapeutic potential in pancreatic cancer.
High levels of TGFβ in patients with pancreatic cancers are associated with poor prognosis 42 . Anti-TGFβ compounds have shown efficacy in preclinical and clinical studies 43, 44 , suppressing liver metastasis by acting on both incoming tumour cells and the liver microenvironment 45 . However, systemic TGFβ inhibition carries a substantial risk for patients as this pathway is implicated in multiple homeostatic processes and may also have tumour-suppressor functions depending on the tumour stage and stromal activation status [46] [47] [48] . Although our data suggest that targeting TGFβ signalling may be beneficial for preventing liver pre-metastatic niche formation, given the context-dependent roles of TGFβ, its potential antitumorigenic effects need to be excluded before TGFβ inhibitors are considered for metastasis prevention in PDAC patients in the clinic.
Several studies have correlated KC (refs 49-51) and ECM changes [52] [53] [54] with circulating tumour cell arrest and liver metastasis. In addition, myeloid cell recruitment to the liver was also shown to precede liver metastasis [55] [56] [57] [58] . Here, we demonstrate for the first time that liver pre-metastatic niche formation during PDAC metastasis depends on tumour exosome-derived MIF. Moreover, we show that this process is driven by TGFβ signalling, FN deposition, and recruitment of bone marrow-derived macrophages to future liver metastatic niches. By individually targeting MIF, FN and macrophages, we successfully reverted the effects of PDAC-derived exosome education at various steps during liver pre-metastatic niche formation. Strategies aimed at targeting these particular molecules (TGFβ, MIF, FN) and cell types (bone marrow-derived cells) have been previously explored 50, [59] [60] [61] [62] . We propose that our detailed dissection of the sequential events of PDAC metastasis initiation provides an understanding of how tumour-secreted factors, specifically exosomes, orchestrate this process and our findings open new avenues for early detection, prevention, and therapeutic intervention.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper
Cells. Primary cultures of murine pancreatic ductal adenocarcinomas (PKCY)
were obtained by dissociating cells from tumours of a 20-week-old Pdx1-Cre transgenic mouse 63 in which a Rosa YFP allele is expressed concurrently with pancreasspecific mutations in p53 and Kras, referred to as PKCY mice 21 . The murine pancreatic tumour cell line with high metastatic potential to the liver, R6560B, was isolated from tumours of a Pdx1-Cre transgenic mouse 63 with pancreasspecific mutations in p53 and Kras (ref. 20) and was generously provided by D. L. Bajor (Vonderheide laboratory, University of Pennsylvania). The C57Bl/6 murine pancreatic adenocarcinoma cell line PAN02 (also identified as Panc 02; ref. 18 ) was purchased from the DTP, DCTD Tumor Repository, NIH. MIF knockdown PAN02 cells were generated by using MIF shRNA lentiviral particle infection, generating the PAN02 variants shMIF (sc-37138-V, Santa Cruz) and shMIF(2) (iV042354, abmGood). As a control, PAN02 cells were infected with control shRNA lentiviral particles-A (sc-108080, Santa Cruz). In all cases, infected cells were selected with puromycin according to the manufacturer's instructions. For several experiments, exosomes were isolated from human PDAC cell lines BxPC-3 and HPAF-II (ATCC). For in vitro education of human Kupffer cells (Life Technologies) with healthy normal pancreas-derived exosomes (NP), PAN02, or BxPC-3 exosomes, cells were maintained in culture for 14 days, with media containing 0 or 5 µg ml −1 of exosomes, replenished every other day. Cells were cultured in RPMI supplemented with 10% exosome-depleted FBS (FBS, Gibco) and penicillin-streptomycin, and maintained in a humid incubator with 5% CO 2 at 37 • C. FBS was depleted of bovine exosomes by ultracentrifugation at 100,000g for 70 min (min). In some experiments, normal pancreas exosomes were obtained by culturing 25 pancreata isolated from healthy 4-6-week-old mice in 3 ml of FBS-free RPMI for 12 h.
Exosome isolation, characterization and analyses. Isolation of exosomes for mass spectrometry and all other experiments was done by ultracentrifugation. Exosome preparation was verified by electron microscopy. Supernatant fractions collected from 72-h cell cultures or plasma samples were pelleted by centrifugation at 500g for 10 min. The supernatant was centrifuged at 12,000g for 20 min. Exosomes were then collected by centrifugation at 100,000g for 70 min. The exosome pellet was resuspended in 20 ml of phosphate-buffered saline (PBS) and collected by ultracentrifugation at 100,000g for 70 min (Beckman Ti70). Exosome size and particle number were analysed using the LM10 or DS500 nanoparticle characterization system (NanoSight) equipped with a blue laser (405 nm). MIF levels in exosomes were measured by ELISA (ab100594, Abcam for human samples; ABIN415583, Antibodies Online for mouse samples), using 2 µg of exosomes per 100 µl of sample diluent, in duplicate reactions, according to the manufacturer's instructions.
Proteomics. Mass spectrometry analyses of exosomes were performed using 10 µg of exosomal protein. Samples were denatured using 8 M urea, reduced using 10 mM dithiothreitol, and alkylated using 100 mM iodoacetamide. This was followed by proteolytic digestion with endoproteinase LysC (Wako Chemicals) overnight at room temperature, and subsequent digestion with trypsin (Promega) for 5 h at 37 • C. The digestion was quenched with formic acid and the resulting peptide mixtures were desalted using in-house-made C18 Empore (3M) StAGE tips. Samples were dried and solubilized in the sample loading buffer containing 2% acetonitrile and 2% formic acid. Approximately 3-5 µg of each sample was analysed by reversed-phase nano-LC-MS/MS (Ultimate 3000 coupled to QExactive, Thermo Scientific). Following loading on the C18 trap column (5 µm beads, Thermo Scientific) at a flow rate of 3 µl min −1 , peptides were separated using a 75-µm-inner-diameter C18 column (3 µm beads Nikkyo Technos) at a flow rate of 200 nl min −1 , with a gradient increasing from 5% Buffer B (0.1% formic acid in acetonitrile)/95% Buffer A (0.1% formic acid) to 40% Buffer B/60% Buffer A, over 140 min. All LC-MS/MS experiments were performed in data-dependent mode. Precursor mass spectra were recorded in a 300-1,400 m/z mass range at 70,000 resolution, and 17,500 resolution for fragment ions (lowest mass: m/z 100). Data were recorded in profile mode. Up to 20 precursors per cycle were selected for fragmentation and dynamic exclusion was set to 45 s. Normalized collision energy was set to 27. Data were extracted and searched against Uniprot complete Human or Mouse proteome databases (January 2013) concatenated with common contaminants using Proteome Discoverer 1.4 (Thermo Scientific) and Mascot 2.4 (Matrix Science). All cysteines were considered alkylated with acetamide. Amino-terminal glutamate to pyroglutamate conversion, oxidation of methionine, and protein N-terminal acetylation were allowed as variable modifications. Data were first searched using fully tryptic constraints. Matched peptides were filtered using a Percolator-based 1% false discovery rate. Spectra not being matched at a false discovery rate of 1% or better were re-searched allowing for semi-tryptic peptides. The average area of the three most abundant peptides for a matched protein was used to gauge protein amounts within and in between samples.
Exosome treatment and labelling. Five micrograms of total exosomal protein was injected into the retro-orbital venous sinus in a total volume of 100 µl PBS. For education experiments, mice received 5 µg of exosomes every other day, 3 times a week. For exosome-tracking experiments, purified exosomes were fluorescently labelled using PKH67 membrane dye (Sigma). Labelled exosomes were washed in 20 ml of PBS, collected by ultracentrifugation, and resuspended in PBS. In experiments involving evaluation of exosome incorporation, labelled exosomes were injected 24 h before tissue collection and analysis for exosome + cells was conducted by flow cytometry or immunofluorescence. For exosome-tracking experiments, 5 µg of nontumour exosomes from normal pancreas were used as controls. Unlabelled exosomes were used as controls of signal specificity. For education experiments, retro-orbital injection of PBS or normal pancreata exosomes was used in control groups.
Illumina strand-specific RNA sequencing. To analyse the genes whose expression was altered in human KC cells as a result of in vitro education with normal pancreas, PAN02, or BxPC-3 exosomes, total RNA was isolated using the RNeasy Mini Kit (QIAGEN). Experiments were performed in triplicate. Illumina sequencing libraries were constructed by following a modified strand-specific RNASeq protocol 64 . The library was then PCR amplified with TruSeq-indexed PCR primers and sequenced using the Illumina HiSeq2000 platform (Weill Cornell Medical College).
Human studies. Human studies were approved by the Weill Cornell Medical College, Institution Review Board no. 0604008488. Human peripheral blood samples were obtained from control healthy subjects and PDAC patients with liver metastasis or from patients without longstanding liver metastasis (approximately 5 years) at Weill Cornell Medical College, Oslo University Hospital, Memorial Sloan Kettering Cancer Center, and University of Nebraska Medical Center, all pathologically confirmed. All individuals provided informed consent for blood donation on approved institutional protocols. Blood was collected in purple-top tubes containing EDTA, and centrifuged at 500g for 10 min. Plasma exosomes were isolated as described above in the Exosome Isolation, Characterization and Analyses section.
Mouse strains and treatments. All mouse work was performed in accordance with institutional, IACUC, and AAALAS guidelines, animal protocol no. 0709-666A. Six-week-old C57Bl/6 female mice were used for all animal experiments. For CD11b + cell depletion, B6.FVB-Tg-(ITGAM-DTR) mice (Jackson Laboratories, stock 006000) were injected intraperitoneally with 150 ng of diphtheria toxin diluted in 100 µl of PBS every other day during the second week of exosome education. As a control, wild-type C57Bl/6 mice received a similar regimen of treatment. CD11b + cell depletion from the liver was verified by immunofluorescence or flow cytometry for F4/80 + cells and CD11b + F4/80 + cells, respectively.
To generate inducible FN knockout mice, we crossed B6;129-Gt(ROSA)26Sor tm1(cre/ERT 2)Tyj /J mice expressing tamoxifen-sensitive Cre under the Gt(Rosa)26or promoter (Jackson Laboratories, stock 008463) with mice homozygous for a floxed allele of fibronectin (Fn fl/fl , generously provided by R. Fässler, Max Planck Institute of Biochemistry) 65 . Cre +/− Fn fl/fl mice were then maintained by breeding to For evaluation of liver pre-metastatic niche formation in a spontaneous mouse model of PDAC, we used the p53-and Kras-driven mouse model of pancreatic cancer 21 , termed PKCY. PKCY mice were evaluated at different ages, during the early and late stages of PanIN lesions (4-6 and 8-11 weeks, respectively), and at the PDAC stage (16-20 weeks). As controls, livers isolated from mice that do not develop pancreatic lesions (Cre transgenic lacking activating TP53 and Kras mutations, referred to here as CY) were used.
For systemic TGFβ receptor inhibition, mice were treated with intraperitoneal injections of A83-01 (Santa Cruz). Mice were administered 10 µg of A83-01 (diluted in 100 µl of dimethylsulphoxide) per gram of mouse weight for a total of 9 doses, every other day, for the three weeks of PAN02 exosome education.
Liver metastasis studies. To analyse the role of exosome education in tumour metastasis, 6-8-week-old C57Bl/6 female mice pre-educated with PDAC-derived exosomes were injected intrasplenically with 1 × 10 6 PAN02 mCherry cells resuspended in 30 µl of Matrigel (Corning) as previously described 19, 66, 67 . Either 24 h or 21 days later, mice were euthanized and livers were analysed for metastatic lesions by counting mCherry + cells by fluorescence microscopy or measuring liver weights. All animals were monitored for abnormal tissue growth or ill effects according to AAALAS guidelines and euthanized if excessive deterioration of animal health was observed.
Flow cytometry analysis. For labelled exosome tracking and phenotypic analysis of murine organs, femurs were flushed and livers were mechanically dissociated, and single-cell suspensions were filtered through a 40 µm strainer. Cells were washed in PBS with 1% BSA and incubated with anti-CD11b-PerCP-Cyanine5.5 (clone M1/70, 1:100, BD Biosciences) and anti-F4/80-APC (clone BM8, 1:100, eBioscience) antibodies at predetermined saturating concentrations. PKH67-labelled exosomepositive cells were detected using blue laser excitation and 488 nm emission. Data for 1,000,000 cells were acquired on a BD FACS Canto cytometer with Diva software (BD) and were analysed using FlowJo software (TreeStar).
Statistical and pathway analysis. Error bars in graphical data represent means ± s.e.m. Statistical significance was determined using a two-tailed Student's ttest or by ANOVA. P < 0.05 was considered statistically significant. Statistical analyses were performed using GraphPad Prism software. Pathway analyses were performed using Ingenuity IPA software (Ingenuity Systems). No statistical method was used to predetermine sample size. The experiments were not randomized, and the investigators were not blinded to allocation during experiments and outcome assessment. 
